Project Grant H8G48888

This Cooperative Agreement award of $150,000 from the Centers for Disease Control and Prevention (CDC) under the Immunization Cooperative Agreements (CFDA 93.268) program will support the Palau Ministry of Health in strengthening vaccine-preventable disease prevention and response efforts. The key objectives are to: 1) Strengthen program infrastructure and management, 2) Increase vaccine access, 3) Improve vaccine equity, 4) Promote vaccine confidence and demand, 5) Enhance data and...

The Vermont Department of Health Immunization Program was awarded a $1,056,227 Cooperative Agreement under the Centers for Disease Control and Prevention (CDC) Investigations and Technical Assistance program (CFDA 93.283). This 5-year award, starting on July 1, 2025, supports public health systems to protect people and communities from vaccine-preventable diseases by increasing access, confidence, and demand for vaccines. The program aims to improve and sustain vaccination coverage, reduce...

The New York City Department of Health and Mental Hygiene (NYC DOHMH) Bureau of Immunization was awarded a $8,029,554 cooperative agreement from the Centers for Disease Control and Prevention (CDC) Investigations and Technical Assistance program (CFDA 93.283) to strengthen vaccine-preventable disease prevention and response in New York City. Over the 5-year project period from July 1, 2025 to June 30, 2030, the award will fund activities to: 1) promote, support, and monitor immunization across...

The Centers for Disease Control and Prevention (CDC) awarded the Oklahoma State Department of Health a $5,580,953 cooperative agreement under the Immunization Research, Demonstration, Public Information and Education Training and Clinical Skills Improvement Projects (CFDA 93.185) program. This funding supports public health efforts to protect people and communities from vaccine-preventable diseases by equitably increasing access, confidence, and demand for vaccines. Key goals of the project...

The Centers for Disease Control and Prevention (CDC) awarded a $3,870,510 Cooperative Agreement under the Immunization Cooperative Agreements (CFDA 93.268) program to the Puerto Rico Department of Health (PRDOH), effective July 1, 2025 through June 30, 2030. The funding will support strengthening vaccine-preventable disease prevention and response in Puerto Rico by: Providing training and technical assistance to vaccine providers to improve immunization practices and increase vaccine confidence;...

The U.S. Centers for Disease Control and Prevention (CDC) awarded a $1,635,687 Cooperative Agreement under the CDC Investigations and Technical Assistance program (CFDA 93.283) to the Delaware Division of Public Health. The award will support efforts to prevent and control the transmission of vaccine-preventable diseases in all ages through high and sustained immunization coverage across the lifespan in Delaware. Key objectives include increasing Vaccines for Children (VFC) program enrollment by...

The Arizona Department of Health Services (ADHS) received a $6,003,421 Cooperative Agreement from the Centers for Disease Control and Prevention (CDC) Investigations and Technical Assistance program (CFDA 93.283) to improve public health outcomes related to vaccine-preventable diseases. The 5-year project, which began on July 1, 2025, will enhance immunization infrastructure, expand vaccine access, and strengthen data quality in Arizona. Key activities include managing vaccine procurement and...

This $199,295 National Science Foundation project grant funded the development of a comparative online simulation tool for COVID-19 vaccine allocation strategies. Funded under the Biological Sciences program (CFDA 47.074), the Fred Hutchinson Cancer Research Center will create a mathematical model of SARS-CoV-2 transmission incorporating multiple vaccines, viral variants, and demographic factors. This model will then be used to develop a free, open-source, online comparative tool allowing up...

This federal Cooperative Agreement award of $1,575,821.00 was provided by the Centers for Disease Control and Prevention (CDC) under the Immunization Cooperative Agreements (CFDA 93.268) program. The award will support the District of Columbia Department of Health (DC Health) in enhancing immunization efforts and reducing vaccine-preventable diseases across the District. Key initiatives include increasing vaccine access, promoting vaccine confidence, improving data collection and reporting,...

The Centers for Disease Control and Prevention (CDC) awarded a $3,423,334 Cooperative Agreement under the Immunization Cooperative Agreements program (CFDA 93.268) to the Maine Department of Health and Human Services (Maine DHHS). The award period is from July 1, 2025 to June 30, 2030. The purpose of the grant is to strengthen vaccine-preventable disease prevention and response efforts in Maine. Key objectives include expanding vaccine access, improving immunization rates, reducing...